Session: Emerging topics: Can removing the fallopian tube lower risk?
Speakers: Ilana Cass, MD; Douglas Levine, MD
This 90-minute concurrent session presents emerging information about hereditary ovarian cancer.
New research suggests that ovarian cancer in BRCA carriers may start in the fallopian tubes.
Drs. Cass and Levine will discuss:
- the latest research and expert opinions on whether all or most hereditary ovarian cancer begins in the fallopian tubes
- approaches to ovarian cancer risk-management based on these findings
- options for lowering the risk for ovarian cancer in high-risk women
- benefits and risks of surgical removal of the fallopian tubes only (salpingectomy)
- importance of consulting with gynecologic-oncologist for preventive surgery and importance of following standard-of-care guidelines for serial sectioning of the fallopian tubes following surgery
This session is appropriate for:
- women who carry a BRCA mutation or who are high risk for ovarian cancer
- breast cancer survivors concerned about their risk for ovarian cancer
- spouses, partners, loved ones of women at high risk for ovarian cancer
- patient advocates, support group facilitators, and people who work with people at high risk for
- health care providers who provide care to women at high risk for ovarian cancer
- social workers/mental health care professionals who women at high risk for